In intraoperative fluid therapy, how do balanced crystalloids compare with colloids in terms of volume expansion and cost?

• A. Balanced crystalloids (e.g., LR) are generally first-line; colloids can expand volume with smaller volumes but cost more and may have adverse effects
• B. Colloids always preferred due to better outcomes
• C. Crystalloids are never used intraoperatively
• D. Crystalloids cause edema and are avoided

Answer: (A)

Intraoperative fluid management hinges on how much intravascular volume you can achieve for a given amount of fluid and what that costs. Balanced crystalloids like lactated Ringer’s are commonly used first because they are inexpensive and have a electrolyte composition that more closely resembles plasma, reducing the risk of acid-base or electrolyte disturbances. They distribute quickly into the extracellular space, so achieving the same intravascular volume expansion requires larger total volumes.

Colloids stay in the intravascular space longer due to their larger molecules and oncotic effect, so a smaller volume can produce a similar rise in circulating volume. However, this speed and efficiency come with higher cost and potential safety concerns, including adverse effects on coagulation and kidney function depending on the product.

So, the practical take-home is that balanced crystalloids are typically the initial choice for routine intraoperative fluid therapy; colloids can provide effective intravascular expansion with less volume but at greater expense and with possible adverse effects.